Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan

A. Abdelrahman, C. C Y Pang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Losartan (DuP 753) and PD123177 are nonpeptide angiotensin (ANG) receptor ligands for subtypes of ANG II receptors ANG II-1 and ANG II-2, respectively. We examined the effects of losartan and PD123177 on dose-mean arterial pressure (MAP) response curves for ANG II and ANG III in eight groups (n = 6 each) of conscious rats. Saline (0.9% NaCl), losartan (1 x 10-6 and 9 x 10-6 mol/kg), and PD123177 (2 x 10-5 mol/kg) were i.v. bolus injected 15 min before the construction of ANG II dose-response curves in groups I, II. III, and IV, respectively. Groups V-VIII were treated similarly to I-IV except that ANG III was given in place of ANG II. Losartan dose dependently shifted the dose-response curves of ANG II and ANG III to the right with similar dissociation constants (-log K(I) of 6.6 ± 0.7 and 6.6 ± 0.1 mol/kg, respectively) and no change in the maxima. PD123177 affected neither maximum MAP nor ED50 values for ANG II or ANG III. Our results show that losartan but not PD123177 is a competitive antagonist of the MAP effects of ANG II and ANG III.

Original languageEnglish
Pages (from-to)716-719
Number of pages4
JournalCanadian Journal of Physiology and Pharmacology
Volume70
Issue number5
Publication statusPublished - 1992

Fingerprint

Angiotensin III
Angiotensin Receptors
Losartan
Angiotensin II
Ligands
Arterial Pressure

Keywords

  • angiotensin II
  • angiotensin III
  • blood pressure
  • losartan
  • nonpeptide angiotensin receptor antagonist

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

@article{31df51b70460420eaf155f81dca60d54,
title = "Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan",
abstract = "Losartan (DuP 753) and PD123177 are nonpeptide angiotensin (ANG) receptor ligands for subtypes of ANG II receptors ANG II-1 and ANG II-2, respectively. We examined the effects of losartan and PD123177 on dose-mean arterial pressure (MAP) response curves for ANG II and ANG III in eight groups (n = 6 each) of conscious rats. Saline (0.9{\%} NaCl), losartan (1 x 10-6 and 9 x 10-6 mol/kg), and PD123177 (2 x 10-5 mol/kg) were i.v. bolus injected 15 min before the construction of ANG II dose-response curves in groups I, II. III, and IV, respectively. Groups V-VIII were treated similarly to I-IV except that ANG III was given in place of ANG II. Losartan dose dependently shifted the dose-response curves of ANG II and ANG III to the right with similar dissociation constants (-log K(I) of 6.6 ± 0.7 and 6.6 ± 0.1 mol/kg, respectively) and no change in the maxima. PD123177 affected neither maximum MAP nor ED50 values for ANG II or ANG III. Our results show that losartan but not PD123177 is a competitive antagonist of the MAP effects of ANG II and ANG III.",
keywords = "angiotensin II, angiotensin III, blood pressure, losartan, nonpeptide angiotensin receptor antagonist",
author = "A. Abdelrahman and Pang, {C. C Y}",
year = "1992",
language = "English",
volume = "70",
pages = "716--719",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "5",

}

TY - JOUR

T1 - Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan

AU - Abdelrahman, A.

AU - Pang, C. C Y

PY - 1992

Y1 - 1992

N2 - Losartan (DuP 753) and PD123177 are nonpeptide angiotensin (ANG) receptor ligands for subtypes of ANG II receptors ANG II-1 and ANG II-2, respectively. We examined the effects of losartan and PD123177 on dose-mean arterial pressure (MAP) response curves for ANG II and ANG III in eight groups (n = 6 each) of conscious rats. Saline (0.9% NaCl), losartan (1 x 10-6 and 9 x 10-6 mol/kg), and PD123177 (2 x 10-5 mol/kg) were i.v. bolus injected 15 min before the construction of ANG II dose-response curves in groups I, II. III, and IV, respectively. Groups V-VIII were treated similarly to I-IV except that ANG III was given in place of ANG II. Losartan dose dependently shifted the dose-response curves of ANG II and ANG III to the right with similar dissociation constants (-log K(I) of 6.6 ± 0.7 and 6.6 ± 0.1 mol/kg, respectively) and no change in the maxima. PD123177 affected neither maximum MAP nor ED50 values for ANG II or ANG III. Our results show that losartan but not PD123177 is a competitive antagonist of the MAP effects of ANG II and ANG III.

AB - Losartan (DuP 753) and PD123177 are nonpeptide angiotensin (ANG) receptor ligands for subtypes of ANG II receptors ANG II-1 and ANG II-2, respectively. We examined the effects of losartan and PD123177 on dose-mean arterial pressure (MAP) response curves for ANG II and ANG III in eight groups (n = 6 each) of conscious rats. Saline (0.9% NaCl), losartan (1 x 10-6 and 9 x 10-6 mol/kg), and PD123177 (2 x 10-5 mol/kg) were i.v. bolus injected 15 min before the construction of ANG II dose-response curves in groups I, II. III, and IV, respectively. Groups V-VIII were treated similarly to I-IV except that ANG III was given in place of ANG II. Losartan dose dependently shifted the dose-response curves of ANG II and ANG III to the right with similar dissociation constants (-log K(I) of 6.6 ± 0.7 and 6.6 ± 0.1 mol/kg, respectively) and no change in the maxima. PD123177 affected neither maximum MAP nor ED50 values for ANG II or ANG III. Our results show that losartan but not PD123177 is a competitive antagonist of the MAP effects of ANG II and ANG III.

KW - angiotensin II

KW - angiotensin III

KW - blood pressure

KW - losartan

KW - nonpeptide angiotensin receptor antagonist

UR - http://www.scopus.com/inward/record.url?scp=0026699968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026699968&partnerID=8YFLogxK

M3 - Article

VL - 70

SP - 716

EP - 719

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 5

ER -